Discover Opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis
This contract includes 1 purchase order from Sep 25, 2018 to Sep 25, 2018
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| National Institutes of Health Nichd | University of California, Davis | Sep 25, 2018 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
NICHD: R&D: BPCA PEDIATRIC DRUG DEVELOPMENT CLINICAL TRIAL INFRASTRUCTURE: SEVERABLE
Effective Date
Jul 25, 2025
Expires
Effective: Jul 25, 2025
NICHD: R&D: BPCA PEDIATRIC DRUG DEVELOPMENT CLINICAL TRIAL INFRASTRUCTURE: SEVERABLE
ActiveNICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: SEVERABLE
Effective Date
Jul 22, 2025
Expires
NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: SEVERABLE
ActiveNICHD: R&D: SPAN ANALYSIS 2025: NON-SEVERABLE
Effective Date
Jul 15, 2025
Expires
Effective: Jul 15, 2025
NICHD: R&D: SPAN ANALYSIS 2025: NON-SEVERABLE
ActiveNICHD: R&D: TO PRODUCE, POTENTIALLY ACQUIRE, MAINTAIN, AND DISTRIBUTE MOUSE MODELS FOR CYTOGENETIC RESEARCH, SPECIFICALLY MODELS FOR DOWN SYNDROME (HUMAN TRISOMY FOR CHROMOSOME 21): SEVERABLE
Effective Date
Sep 22, 2025
Expires
Effective: Sep 22, 2025
NICHD: R&D: TO PRODUCE, POTENTIALLY ACQUIRE, MAINTAIN, AND DISTRIBUTE MOUSE MODELS FOR CYTOGENETIC RESEARCH, SPECIFICALLY MODELS FOR DOWN SYNDROME (HUMAN TRISOMY FOR CHROMOSOME 21): SEVERABLE
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis